Inceptua: Risen through the ranks
Luxembourg-based Inceptua has named Stefan Fraenkel as its new CEO. Fraenkel has been in charge of creating the Inceptuas business unit Inceptua Pharma since 2017.
He holds an MBA and a Ph.D. in international economics. Prior to joining Inceptua, Fraenkel served Head of Corporate Development at Swedish Orphan Biovitrum AB. Prior to Sobi, Stefan worked at Wyeth/Pfizer where he held various international commercial leadership positions in Europe and in the USA.
Biocytogen Co Ltd
Draupnir Bio ApS